Your browser doesn't support javascript.
loading
Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma.
Santoni, Matteo; Massari, Francesco; Matrana, Marc R; Basso, Umberto; De Giorgi, Ugo; Aurilio, Gaetano; Buti, Sebastiano; Incorvaia, Lorena; Rizzo, Mimma; Martignetti, Angelo; Maslov, Diana; Tawagi, Karine; Philon, Ernest; Blake, Zoe; Porta, Camillo; Battelli, Nicola.
Afiliação
  • Santoni M; Oncology Unit, Macerata Hospital, Via Santa Lucia 2, 62100, Macerata, Italy. Electronic address: mattymo@alice.it.
  • Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy.
  • Matrana MR; Department of Internal Medicine, Hematology/Oncology, Ochsner Medical Center, New Orleans, LA, USA.
  • Basso U; Oncology 3 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.
  • De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Aurilio G; Medical Oncology Division of Urogenital and Head and Neck Tumours, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Incorvaia L; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.
  • Rizzo M; Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Piazza G. Cesare 11, 70124 Bari, Italy.
  • Martignetti A; Dipartimento oncologico usl sud-est toscana-area senese, Località Campostaggia s.n.c., 53036 Poggibonsi, Italy.
  • Maslov D; Department of Internal Medicine, Hematology/Oncology, Ochsner Medical Center, New Orleans, LA, USA.
  • Tawagi K; Department of Internal Medicine, Hematology/Oncology, Ochsner Medical Center, New Orleans, LA, USA.
  • Philon E; Department of Internal Medicine, Hematology/Oncology, Ochsner Medical Center, New Orleans, LA, USA.
  • Blake Z; Department of Internal Medicine, Hematology/Oncology, Ochsner Medical Center, New Orleans, LA, USA.
  • Porta C; Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Piazza G. Cesare 11, 70124 Bari, Italy; Chair of Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
  • Battelli N; Oncology Unit, Macerata Hospital, Via Santa Lucia 2, 62100, Macerata, Italy.
Eur J Cancer ; 172: 191-198, 2022 09.
Article em En | MEDLINE | ID: mdl-35780525
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Inibidores de Hidroximetilglutaril-CoA Redutases / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child, preschool / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Inibidores de Hidroximetilglutaril-CoA Redutases / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child, preschool / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article